Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid

ConclusionsConsequently, SOR and UA combination could be a new therapeutic strategy for HCC treatment.

Source: Journal of Pharmacy and Pharmacology - April 24, 2019 Category: Drugs & Pharmacology Authors: Beste Yurdacan, Unal Egeli, Gamze Guney Eskiler, Isil Ezgi Eryilmaz, Gulsah Cecener, Berrin Tunca Tags: Research Paper Source Type: research